Results 51 to 60 of about 1,026 (107)

Evaluating the pharmacodynamic effects of padsevonil in healthy volunteers using simultaneous [¹¹C]-UCB-J PET and MR Arterial Spin Labeling measurements. [PDF]

Neurosci Appl, 2023
Koole M, Lacroix B, Tang C, Chanteux H, Maguire RP, Van Laere K.   +5 more
europepmc   +1 more source

Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [¹¹ C]UCB-J. [PDF]

Alzheimers Dement, 2022
Mecca AP, O'Dell RS, Sharp ES, Banks ER, Bartlett HH, Zhao W, Lipior S, Diepenbrock NG, Chen MK, Naganawa M, Toyonaga T, Nabulsi NB, Vander Wyk BC, Arnsten AFT, Huang Y, Carson RE, van Dyck CH.   +16 more
europepmc   +1 more source

Drug characteristics derived from kinetic modeling: combined ¹¹C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A. [PDF]

EJNMMI Res, 2022
Naganawa M, Gallezot JD, Finnema SJ, Maguire RP, Mercier J, Nabulsi NB, Kervyn S, Henry S, Nicolas JM, Huang Y, Chen MK, Hannestad J, Klitgaard H, Stockis A, Carson RE.   +14 more
europepmc   +1 more source

Human biodistribution and dosimetry of [¹¹C]-UCB-J, a PET radiotracer for imaging synaptic density. [PDF]

EJNMMI Phys, 2021
Cawthorne C, Maguire P, Mercier J, Sciberras D, Serdons K, Bormans G, de Hoon J, Van Laere K, Koole M.   +8 more
europepmc   +1 more source

Synaptic density in carriers of C9orf72 mutations: a [¹¹ C]UCB-J PET study. [PDF]

Ann Clin Transl Neurol, 2021
Malpetti M, Holland N, Jones PS, Ye R, Cope TE, Fryer TD, Hong YT, Savulich G, Rittman T, Passamonti L, Mak E, Aigbirhio FI, O'Brien JT, Rowe JB.   +13 more
europepmc   +1 more source

Additional file 1 of Evaluation of the impact of low activity imaging in [11C]-(+)-PHNO and [11C]UCB-J PET-MR scans

Supplementary Material 1.
Ribeiro, Daniela, Hallett, William, Howes, Oliver, McCutcheon, Robert, Nour, Matthew M., Nutt, David, Erritzoe, David, Agnorelli, Claudio, Husbands, Stephen   +8 more
openaire   +1 more source

Changes in synaptic density in the subacute phase after ischemic stroke: A ¹¹C-UCB-J PET/MR study. [PDF]

J Cereb Blood Flow Metab, 2022
Michiels L, Mertens N, Thijs L, Radwan A, Sunaert S, Vandenbulcke M, Verheyden G, Koole M, Van Laere K, Lemmens R.   +9 more
europepmc   +1 more source

Simplified Quantification of ¹¹C-UCB-J PET Evaluated in a Large Human Cohort. [PDF]

J Nucl Med, 2021
Naganawa M, Gallezot JD, Finnema SJ, Matuskey D, Mecca A, Nabulsi NB, Labaree D, Ropchan J, Malison RT, D'Souza DC, Esterlis I, Detyniecki K, van Dyck CH, Huang Y, Carson RE.   +14 more
europepmc   +1 more source

Associations between fluid biomarkers and PET imaging ([11C]UCB-J) of synaptic pathology in Alzheimer's disease. [PDF]

Alzheimers Dement
Nilsson J, Mecca AP, Ashton NJ, Salardini E, O'Dell RS, Carson RE, Benedet AL, Blennow K, Zetterberg H, van Dyck CH, Brinkmalm A.   +10 more
europepmc   +1 more source

Comparison of [¹¹C]UCB-J and [¹⁸F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study. [PDF]

J Cereb Blood Flow Metab, 2021
Chen MK, Mecca AP, Naganawa M, Gallezot JD, Toyonaga T, Mondal J, Finnema SJ, Lin SF, O'Dell RS, McDonald JW, Michalak HR, Vander Wyk B, Nabulsi NB, Huang Y, Arnsten AF, van Dyck CH, Carson RE.   +16 more
europepmc   +1 more source